SynthesisInternational journal of molecular sciences2026
Metabolic Benefits vs. Cardiovascular Uncertainty: A Critical Review of GLP-1 Receptor Agonists in Type 1 Diabetes.
Elżbieta Wójcik-Sosnowska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.